Supplemental material for JAAD-D-21-01612R2. Atopic dermatitis and the risk of eating disorders: a population-based cohort study
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Supplemental material and supplemental table.
应用场景：
创建时间：
2021-10-18
相关数据集
Additional file 1 of A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis
Additional file 1: Supplementary data. A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis. Supplementary figure 1. NMR
DataCite Commons2020-08-25 更新130
Amygdalin alleviates atopic dermatitis-like skin inflammation via inhibition of Th2 immune responses
Atopic dermatitis (AD) is a chronic skin disease marked by immune dysregulation such as upregulated T helper (Th) 2 responses. While Th2-targeted therapies for AD are under development, their applicat
DataCite Commons2025-09-29 更新110
Early itch relief with ivarmacitinib improves quality of life, working productivity, and sleep quality in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of a phase III trial
Ivarmacitinib (SHR0302), a selective Janus kinase-1 inhibitor, is a novel treatment for moderate-to-severe atopic dermatitis (AD). This post hoc analysis evaluated the impact of early itch relief with
DataCite Commons2025-12-16 更新20
Additional file 9: Table E5. of Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
Khattri 2014 (GSE58558) – Ingenuity Pathway Analysis. (XLSX 26 kb)
DataCite Commons2024-12-18 更新120
The stratum corneum transcriptome in atopic dermatitis can be assessed by tape stripping
Background: Skin biopsies represent a gold standard in skin immunology and pathology but can cause pain and induce scarring. Non-invasive techniques will facilitate study recruitment of e.g. patients
干细胞与再生医学数据中心2022-02-20 更新110
